1|Page
Test Bank for CURRENT Medical Diagnosis and
Treatment 2026 64th Edition |Comprehensive Exam
Preparation Resource |Internal Medicine Clinical
Diagnosis and Treatment |CURRENT Medical
Diagnosis and Treatment (CMDT) 2026 - 64th Edition
Description: This comprehensive test bank is designed for medical
students, internal medicine residents, and healthcare professionals
preparing for clinical examinations. Based on the globally trusted
CMDT 2026 textbook by Papadakis, Rabow, McQuaid, Gandhi, and
Nadler, this resource covers over 1,000 diseases and disorders across 48
chapters. Questions focus on evidence-based diagnosis, pharmacologic
management, diagnostic testing, and preventive medicine across all
major body systems. The content reflects the latest 2026 clinical
guidelines including the AHA PREVENT equations and GOLD 2026
COPD criteria.
SECTION 1: PREVENTIVE MEDICINE & HEALTH PROMOTION
Question 1
A 68-year-old man with a history of hypertension asks about influenza
vaccination. What is the recommended influenza vaccine for his age
group?
A) Standard-dose quadrivalent inactivated influenza vaccine
,2|Page
B) High-dose or adjuvanted influenza vaccine
C) Live attenuated influenza vaccine (nasal spray)
D) No vaccine is needed after age 65
Answer: B
*Adults aged 65 years and older should receive high-dose (Fluzone
High-Dose) or adjuvanted (Fluad) influenza vaccine because these
formulations provide superior protection in older adults. Standard-dose
vaccines are acceptable if high-dose is unavailable. Live attenuated
influenza vaccine is contraindicated in older adults.*
---
Question 2
A 50-year-old woman with no cardiovascular risk factors asks about
aspirin for primary prevention. According to current guidelines, what is
recommended?
A) Aspirin 81 mg daily
B) Aspirin 325 mg daily
C) No aspirin for primary prevention in this age group without elevated
risk
D) Aspirin only if she has a family history of MI
,3|Page
Answer: C
*Current guidelines do not recommend routine aspirin for primary
prevention in adults aged 60 years and older. For adults aged 40-59 years
with 10% 10-year CVD risk, the decision should be individualized. This
patient has no risk factors, so aspirin is not indicated.*
---
Question 3
A 62-year-old woman presents for a wellness visit. She received her last
tetanus-diphtheria (Td) booster 12 years ago. What vaccine is indicated?
A) Tdap (tetanus, diphtheria, pertussis) booster
B) Td (tetanus, diphtheria) booster
C) No vaccine indicated
D) Only tetanus vaccine
Answer: A
*Tdap should be given once to all adults, regardless of prior vaccination
history, with subsequent Td or Tdap boosters every 10 years. Since this
patient is due for a booster and has no documented Tdap, Tdap is
indicated.*
, 4|Page
---
Question 4
A 68-year-old man with a 40-pack-year smoking history quit smoking 1
year ago. He has no respiratory symptoms. Does he qualify for lung
cancer screening?
A) Yes, because he has a 20+ pack-year history and quit within the past
15 years
B) No, because he quit more than 1 year ago
C) No, because he has no symptoms
D) Yes, only if he has COPD
Answer: A
*Eligibility for LDCT lung cancer screening includes adults aged 50-80
years with a 20-pack-year smoking history who currently smoke or have
quit within the past 15 years. This patient qualifies despite being
asymptomatic and having quit 1 year ago.*
---
Question 5
A 70-year-old woman has a BMI of 35 kg/m². According to USPSTF,
what is recommended for obesity screening?
Test Bank for CURRENT Medical Diagnosis and
Treatment 2026 64th Edition |Comprehensive Exam
Preparation Resource |Internal Medicine Clinical
Diagnosis and Treatment |CURRENT Medical
Diagnosis and Treatment (CMDT) 2026 - 64th Edition
Description: This comprehensive test bank is designed for medical
students, internal medicine residents, and healthcare professionals
preparing for clinical examinations. Based on the globally trusted
CMDT 2026 textbook by Papadakis, Rabow, McQuaid, Gandhi, and
Nadler, this resource covers over 1,000 diseases and disorders across 48
chapters. Questions focus on evidence-based diagnosis, pharmacologic
management, diagnostic testing, and preventive medicine across all
major body systems. The content reflects the latest 2026 clinical
guidelines including the AHA PREVENT equations and GOLD 2026
COPD criteria.
SECTION 1: PREVENTIVE MEDICINE & HEALTH PROMOTION
Question 1
A 68-year-old man with a history of hypertension asks about influenza
vaccination. What is the recommended influenza vaccine for his age
group?
A) Standard-dose quadrivalent inactivated influenza vaccine
,2|Page
B) High-dose or adjuvanted influenza vaccine
C) Live attenuated influenza vaccine (nasal spray)
D) No vaccine is needed after age 65
Answer: B
*Adults aged 65 years and older should receive high-dose (Fluzone
High-Dose) or adjuvanted (Fluad) influenza vaccine because these
formulations provide superior protection in older adults. Standard-dose
vaccines are acceptable if high-dose is unavailable. Live attenuated
influenza vaccine is contraindicated in older adults.*
---
Question 2
A 50-year-old woman with no cardiovascular risk factors asks about
aspirin for primary prevention. According to current guidelines, what is
recommended?
A) Aspirin 81 mg daily
B) Aspirin 325 mg daily
C) No aspirin for primary prevention in this age group without elevated
risk
D) Aspirin only if she has a family history of MI
,3|Page
Answer: C
*Current guidelines do not recommend routine aspirin for primary
prevention in adults aged 60 years and older. For adults aged 40-59 years
with 10% 10-year CVD risk, the decision should be individualized. This
patient has no risk factors, so aspirin is not indicated.*
---
Question 3
A 62-year-old woman presents for a wellness visit. She received her last
tetanus-diphtheria (Td) booster 12 years ago. What vaccine is indicated?
A) Tdap (tetanus, diphtheria, pertussis) booster
B) Td (tetanus, diphtheria) booster
C) No vaccine indicated
D) Only tetanus vaccine
Answer: A
*Tdap should be given once to all adults, regardless of prior vaccination
history, with subsequent Td or Tdap boosters every 10 years. Since this
patient is due for a booster and has no documented Tdap, Tdap is
indicated.*
, 4|Page
---
Question 4
A 68-year-old man with a 40-pack-year smoking history quit smoking 1
year ago. He has no respiratory symptoms. Does he qualify for lung
cancer screening?
A) Yes, because he has a 20+ pack-year history and quit within the past
15 years
B) No, because he quit more than 1 year ago
C) No, because he has no symptoms
D) Yes, only if he has COPD
Answer: A
*Eligibility for LDCT lung cancer screening includes adults aged 50-80
years with a 20-pack-year smoking history who currently smoke or have
quit within the past 15 years. This patient qualifies despite being
asymptomatic and having quit 1 year ago.*
---
Question 5
A 70-year-old woman has a BMI of 35 kg/m². According to USPSTF,
what is recommended for obesity screening?
